Gregory B Tallman

Years Active: 2018-2023
Publications (10 Years): 5

Pacific University School of Pharmacy

Oregon Health and Science University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pacific University School of Pharmacy Jul 18 2018

United States

Assistant Professor of Pharmacy Practice

Oregon State University College of Pharmacy - Jun 30 2018

United States

Clinical Fellow :: Pharmacy Practice

Mercy Medical Center

United States

PGY-2 Infectious Diseases Pharmacy Resident :: Pharmacy

Hy-Vee

United States

Float Pharmacist

Mercy Medical Center

United States

PGY-1 Pharmacy Resident :: Pharmacy

Hy-Vee

United States

Student Pharmacist

Education History

Oregon Health and Science University

United States

MSC

Drake University College of Pharmacy and Heath Sciences - May 18 2013

United States

PHD

Publications

Caitlin M McCracken, Kendall J Tucker, Gregory B Tallman, Haley K Holmer, Brie N Noble, Jessina C McGregor
General Perceptions and Knowledge of Antibiotic Resistance and Antibiotic Use Behavior: A Cross-Sectional Survey of US Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Caitlin M McCracken, Kendall J Tucker, Gregory B Tallman, Haley K Holmer, Brie N Noble, Jessina C McGregor
General Perceptions and Knowledge of Antibiotic Resistance and Antibiotic Use Behavior: A Cross-Sectional Survey of US Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Oula Samaan, Dana Bojorquez, Gregory B Tallman
Comment: Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting. The Annals of pharmacotherapy (2022)
Christina D Bowen, Gregory B Tallman, Morgan Hakki, James S Lewis Ⅱ
Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre. Mycoses 62 (8) (2019)
Jon P Furuno, Gregory B Tallman, Brie N Noble, Joseph S Bubalo, Graeme N Forrest, James S Lewis, Ana F Bienvenida, Courtney A Holmes, Bo R Weber, Jessina C McGregor
Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections. Antimicrobial agents and chemotherapy 62 (10) (2018)

Gregory B Tallman.css-eqlu8i{font-size:small;padding-left:4px;}